<?xml version = '1.0' encoding = 'UTF-8'?>
<?xml-stylesheet href="/rss/styledrssBMC.css" type="text/css"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:extra="http://www.biomedcentral.com/xml/schemas/extra/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:cc="http://web.resource.org/cc/">
	<channel rdf:about="http://www.biomedcentral.com/rss">
		<extra:info rdf:parseType="Literal">
			<html:div xmlns:html="http://www.w3.org/1999/xhtml" style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif">
				<html:span style="font-weight:bold">This is an RSS newsfeed from BioMed Central</html:span>
				<html:br/>
				<html:span style="font-size: 12px;">It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit <html:br/><html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">http://www.biomedcentral.com/info/about/rss/</html:a><html:br/>
				</html:span>
			</html:div>
		</extra:info>
		<title>Virology Journal - Latest articles</title>
		<link>http://www.virologyj.com</link>
		<description>The latest articles from Virology Journal (ISSN 1743-422X) published by 
				
				BioMed Central
		</description>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        <items>
            <rdf:Seq>
            
				    <rdf:li rdf:resource="http://www.virologyj.com/content/5/1/115"/>			    
            
				    <rdf:li rdf:resource="http://www.virologyj.com/content/5/1/114"/>			    
            
				    <rdf:li rdf:resource="http://www.virologyj.com/content/5/1/113"/>			    
            
				    <rdf:li rdf:resource="http://www.virologyj.com/content/5/1/112"/>			    
            
				    <rdf:li rdf:resource="http://www.virologyj.com/content/5/1/111"/>			    
            
				    <rdf:li rdf:resource="http://www.virologyj.com/content/5/1/110"/>			    
            
				    <rdf:li rdf:resource="http://www.virologyj.com/content/5/1/109"/>			    
            
				    <rdf:li rdf:resource="http://www.virologyj.com/content/5/1/108"/>			    
            
				    <rdf:li rdf:resource="http://www.virologyj.com/content/5/1/107"/>			    
            
				    <rdf:li rdf:resource="http://www.virologyj.com/content/5/1/106"/>			    
            
            </rdf:Seq>
        </items>
    </channel>  
    
		<item rdf:about="http://www.virologyj.com/content/5/1/115">
            
            <title>Molecular characterization of Umbre virus (Bunyaviridae) </title>
			<description>Umbre (UMB) virus was first isolated from India in 1955 and classified as Orthobunyavirus (Turlock serogroup). Eight isolates of this virus, isolated from Culex mosquitoes were characterized on the basis of partial glycoprotein (G2) gene. Twenty-six percent differences at nucleotide level while 17% differences at amino acid level were noted within different isolates. Phylogentic data shows that this virus represents a distinct group within the genus Orthobunyavirus.</description>
			<link>http://www.virologyj.com/content/5/1/115</link>
			
			 	<dc:creator>Pragya D Yadav, Devendra T Mourya and Akhilesh C Mishra</dc:creator>
			
			<dc:source>Virology Journal 2008, 5:115</dc:source>
			<dc:date>2008-10-08</dc:date>
			<dc:identifier>doi:10.1186/1743-422X-5-115</dc:identifier>
			
			
							
					<prism:publicationName>Virology Journal</prism:publicationName>
					
			
							
					<prism:issn>1743-422X</prism:issn>
					
			
							
					<prism:volume>5</prism:volume>
					
			
							
					<prism:startingPage>115</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-10-08</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.virologyj.com/content/5/1/114">
            
            <title>Inhibition of G1P3 expression found in the differential display study on respiratory syncytial virus infection</title>
			<description>Background:
Respiratory syncytial virus (RSV) is the leading viral pathogen associated with bronchiolitis and lower respiratory tract disease in infants and young children worldwide. The respiratory epithelium is the primary initiator of pulmonary inflammation in RSV infections, which cause significant perturbations of global gene expression controlling multiple cellular processes. In this study, differential display reverse transcription polymerase chain reaction amplification was performed to examine mRNA expression in a human alveolar cell line (SPC-A1) infected with RSV.
Results:
Of the 2,500 interpretable bands on denaturing polyacrylamide gels, 40 (1.6%) cDNA bands were differentially regulated by RSV, in which 28 (70%) appeared to be upregulated and another 12 (30%) appeared to be downregulated. Forty of the expressed sequence tags (EST) were isolated, and 20 matched homologs in GenBank. RSV infection upregulated the mRNA expression of chemokines CC and CXC and interfered with type one/two interferon-inducible gene expression by upregulation of MG11 and downregulation of G1P3.
Conclusions:
RSV replication could induce widespread changes in gene expression including both positive and negative regulation and play a different role in the down-regulation of IFN-alpha and up-regulation of IFN-gamma inducible gene expression, which suggests that RSV interferes with the innate antiviral response of epithelial cells by multiple mechanisms.</description>
			<link>http://www.virologyj.com/content/5/1/114</link>
			
			 	<dc:creator>Dong-chi Zhao, Dan Peng, Lei Li, Qiwei Zhang and Chuyu Zhang</dc:creator>
			
			<dc:source>Virology Journal 2008, 5:114</dc:source>
			<dc:date>2008-10-06</dc:date>
			<dc:identifier>doi:10.1186/1743-422X-5-114</dc:identifier>
			
			
							
					<prism:publicationName>Virology Journal</prism:publicationName>
					
			
							
					<prism:issn>1743-422X</prism:issn>
					
			
							
					<prism:volume>5</prism:volume>
					
			
							
					<prism:startingPage>114</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-10-06</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.virologyj.com/content/5/1/113">
            
            <title>Molecular characterization of highly pathogenic H5N1 avian influenza viruses isolated in Sweden in 2006</title>
			<description>Background:
The analysis of the nonstructural (NS) gene of the highly pathogenic (HP) H5N1 avian influenza viruses (AIV) isolated in Sweden early 2006 indicated the co-circulation of two sub-lineages of these viruses at that time. In order to complete the information on their genetic features and relation to other HP H5N1 AIVs the seven additional genes of twelve Swedish isolates were amplified in full length, sequenced, and characterized.
Results:
The presence of two sub-lineages of HP H5N1 AIVs in Sweden in 2006 was further confirmed by the phylogenetic analysis of approximately the 95% of the genome of twelve isolates that were selected on the base of differences in geographic location, timing and animal species of origin. Ten of the analyzed viruses belonged to sub-clade 2.2.2. and grouped together with German and Danish isolates, while two 2.2.1. sub-clade viruses formed a cluster with isolates of Egyptian, Italian, Slovenian, and Nigerian origin. The revealed amino acid differences between the two sub-groups of Swedish viruses affected the predicted antigenicity of the surface glycoproteins, haemagglutinin and neuraminidase, rather than the nucleoprotein, polymerase basic protein 2, and polymerase acidic protein, the main targets of the cellular immune responses. The distinctive characteristics between members of the two subgroups were identified and described. 
Conclusion:
The comprehensive genetic characterization of HP H5N1 AIVs isolated in Sweden during the spring of 2006 is reported. Our data support previous findings on the coincidental spread of multiple sub-lineage H5N1 HPAIVs via migrating aquatic birds to large distance from their origin. The detection of 2.2.1. sub-clade viruses in Sweden adds further data regarding their spread in the North of Europe in 2006. The close genetic relationship of Swedish isolates sub-clade 2.2.2. to the contemporary German and Danish isolates supports the proposition of the introduction and spread of a single variant of 2.2.2. sub-clade H5N1 avian influenza viruses in the Baltic region. The presented findings underline the importance of whole genome analysis.</description>
			<link>http://www.virologyj.com/content/5/1/113</link>
			
			 	<dc:creator>Istvan Kiss, Peter Gyarmati, Siamak Zohari, Karin Wilbe Ramsay, Giorgi Metreveli, Elisabeth Weiss, Maria Brytting, Marielle Stivers, Sofia Lindstrom, Ake Lundkvist, Kirill Nemirov, Peter Thoren, Mikael Berg, Gyorgy Czifra and Sandor Belak</dc:creator>
			
			<dc:source>Virology Journal 2008, 5:113</dc:source>
			<dc:date>2008-10-06</dc:date>
			<dc:identifier>doi:10.1186/1743-422X-5-113</dc:identifier>
			
			
							
					<prism:publicationName>Virology Journal</prism:publicationName>
					
			
							
					<prism:issn>1743-422X</prism:issn>
					
			
							
					<prism:volume>5</prism:volume>
					
			
							
					<prism:startingPage>113</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-10-06</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.virologyj.com/content/5/1/112">
            
            <title>Torque teno virus: an improved indicator for viral pathogens in drinking waters</title>
			<description>Background:
Currently applied indicator organism systems, such as coliforms, are not fully protective of public health from enteric viruses in water sources. Waterborne disease outbreaks have occurred in systems that tested negative for coliforms, and positive coliform results do not necessarily correlate with viral risk. It is widely recognized that bacterial indicators do not co-occur exclusively with infectious viruses, nor do they respond in the same manner to environmental or engineered stressors. Thus, a more appropriate indicator of health risks from infectious enteric viruses is needed.Presentation of the hypothesisTorque teno virus is a small, non-enveloped DNA virus that likely exhibits similar transport characteristics to pathogenic enteric viruses. Torque teno virus is unique among enteric viral pathogens in that it appears to be ubiquitous in humans, elicits seemingly innocuous infections, and does not exhibit seasonal fluctuations or epidemic spikes. Torque teno virus is transmitted primarily via the fecal-oral route and can be assayed using rapid molecular techniques. We hypothesize that Torque teno virus is a more appropriate indicator of viral pathogens in drinking waters than currently used indicator systems based solely on bacteria.Testing the hypothesisTo test the hypothesis, a multi-phased research approach is needed. First, a reliable Torque teno virus assay must be developed. A rapid, sensitive, and specific PCR method using established nested primer sets would be most appropriate for routine monitoring of waters. Because PCR detects both infectious and inactivated virus, an in vitro method to assess infectivity also is needed. The density and occurrence of Torque teno virus in feces, wastewater, and source waters must be established to define spatial and temporal stability of this potential indicator. Finally, Torque teno virus behavior through drinking water treatment plants must be determined with co-assessment of traditional indicators and enteric viral pathogens to assess whether correlations exist. Implications of the hypothesisIf substantiated, Torque teno virus could provide a completely new, reliable, and efficient indicator system for viral pathogen risk. This indicator would have broad application to drinking water utilities, watershed managers, and protection agencies and would provide a better means to assess viral risk and protect public health.</description>
			<link>http://www.virologyj.com/content/5/1/112</link>
			
			 	<dc:creator>Jennifer S Griffin, Jeanine D Plummer and Sharon C Long</dc:creator>
			
			<dc:source>Virology Journal 2008, 5:112</dc:source>
			<dc:date>2008-10-03</dc:date>
			<dc:identifier>doi:10.1186/1743-422X-5-112</dc:identifier>
			
			
							
					<prism:publicationName>Virology Journal</prism:publicationName>
					
			
							
					<prism:issn>1743-422X</prism:issn>
					
			
							
					<prism:volume>5</prism:volume>
					
			
							
					<prism:startingPage>112</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-10-03</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.virologyj.com/content/5/1/111">
            
            <title>Molecular and macromolecular alterations of recombinant adenoviral vectors do not resolve changes in hepatic drug metabolism during infection</title>
			<description>In this report we test the hypothesis that long-term virus-induced alterations in CYP occur from changes initiated by the virus that may not be related to the immune response. Enzyme activity, protein expression and mRNA of CYP3A2, a correlate of human CYP3A4, and CYP2C11, responsive to inflammatory mediators, were assessed 0.25, 1, 4, and 14 days after administration of several different recombinant adenoviruses at a dose of 5.7 &#215; 1012 virus particles (vp)/kg to male Sprague Dawley rats. Wild type adenovirus, containing all viral genes, suppressed CYP3A2 and 2C11 activity by 37% and 39%, respectively within six hours. Levels fell to 67% (CYP3A2) and 79% (CYP2C11) of control by 14 days (p &#8804; 0.01). Helper-dependent adenovirus, with all viral genes removed, suppressed CYP3A2 (43%) and CYP2C11 (55%) within six hours. CYP3A2 remained significantly suppressed (47%, 14 days, p &#8804; 0.01) while CYP2C11 returned to baseline at this time. CYP3A2 and 2C11 were reduced by 45 and 42% respectively 6 hours after treatment with PEGylated adenovirus, which has a low immunological profile (p &#8804; 0.05). CYP3A2 remained suppressed (34%, p &#8804; 0.05) for 14 days while CYP2C11 recovered. Inactivated virus suppressed CYP3A2 activity by 25&#8211;50% for 14 days (p &#8804; 0.05). CYP2C11 was affected similar manner but recovered by day 14. Microarray and in vitro studies suggest that changes in cellular signaling pathways initiated early in virus infection contribute to changes in CYP.</description>
			<link>http://www.virologyj.com/content/5/1/111</link>
			
			 	<dc:creator>Shellie M Callahan, Piyanuch Wonganan and Maria A Croyle</dc:creator>
			
			<dc:source>Virology Journal 2008, 5:111</dc:source>
			<dc:date>2008-09-30</dc:date>
			<dc:identifier>doi:10.1186/1743-422X-5-111</dc:identifier>
			
			
							
					<prism:publicationName>Virology Journal</prism:publicationName>
					
			
							
					<prism:issn>1743-422X</prism:issn>
					
			
							
					<prism:volume>5</prism:volume>
					
			
							
					<prism:startingPage>111</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-09-30</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.virologyj.com/content/5/1/110">
            
            <title>Hantaviruses and TNF-alpha act synergistically to induce ERK1/2 inactivation in Vero E6 cells</title>
			<description>Background:
We have previously reported that the apathogenic Tula hantavirus induces apoptosis in Vero E6 epithelial cells. To assess the molecular mechanisms behind the induced apoptosis we studied the effects of hantavirus infection on cellular signaling pathways which promote cell survival. We previously also observed that the Tula virus-induced cell death process is augmented by external TNF-alpha. Since TNF-alpha is involved in the pathogenesis of hantavirus-caused hemorrhagic fever with renal syndrome (HFRS) we investigated its effects on HFRS-causing hantavirus-infected cells. 
Results:
We compared apathogenic (Tula and Topografov) and pathogenic (Puumala and Seoul) hantaviruses in their ability to regulate cellular signaling pathways and observed a direct virus-mediated down-regulation of external signal-regulated kinases 1 and 2 (ERK1/2) survival pathway activity, which was dramatically enhanced by TNF-alpha. The fold of ERK1/2 inhibition correlated with viral replication efficiencies, which varied drastically between the hantaviruses studied.
Conclusions:
We demonstrate that in the presence of a cytokine TNF-alpha, which is elevated in HFRS patients, hantaviruses are capable of inactivating proteins that promote cell survival (ERK1/2). These results imply hantavirus-infected epithelial cell barrier functions might be compromised in diseased individuals and could at least partially explain the mechanisms of renal dysfunction and the resulting proteinuria seen in HFRS patients. </description>
			<link>http://www.virologyj.com/content/5/1/110</link>
			
			 	<dc:creator>Tomas Strandin, Jussi Hepojoki, Hao Wang, Antti Vaheri and Hilkka Lankinen</dc:creator>
			
			<dc:source>Virology Journal 2008, 5:110</dc:source>
			<dc:date>2008-09-29</dc:date>
			<dc:identifier>doi:10.1186/1743-422X-5-110</dc:identifier>
			
			
							
					<prism:publicationName>Virology Journal</prism:publicationName>
					
			
							
					<prism:issn>1743-422X</prism:issn>
					
			
							
					<prism:volume>5</prism:volume>
					
			
							
					<prism:startingPage>110</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-09-29</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.virologyj.com/content/5/1/109">
            
            <title>Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay</title>
			<description>Background:
The emergence of influenza strains that are resistant to commonly used antivirals has highlighted the need to develop new compounds that target viral gene products or host mechanisms that are essential for effective virus replication. Existing assays to identify potential antiviral compounds often use high throughput screening assays that target specific viral replication steps. To broaden the search for antivirals, cell-based replication assays can be performed, but these are often labor intensive and have limited throughput.
Results:
We have adapted a traditional virus neutralization assay to develop a practical, cell-based, high throughput screening assay. This assay uses viral neuraminidase (NA) as a read-out to quantify influenza replication, thereby offering an assay that is both rapid and sensitive. In addition to identification of inhibitors that target either viral or host factors, the assay allows simultaneous evaluation of drug toxicity. Antiviral activity was demonstrated for a number of known influenza inhibitors including amantadine that targets the M2 ion channel, zanamivir that targets NA, ribavirin that targets IMP dehydrogenase, and bis-indolyl maleimide that targets protein kinase A/C. Amantadine-resistant strains were identified by comparing IC50 with that of the wild-type virus.
Conclusion:
Antivirals with specificity for a broad range of targets are easily identified in an accelerated viral inhibition assay that uses NA as a read-out of replication. This assay is suitable for high throughput screening to identify potential antivirals or can be used to identify drug-resistant influenza strains.</description>
			<link>http://www.virologyj.com/content/5/1/109</link>
			
			 	<dc:creator>Maryna C Eichelberger, Arash Hassantoufighi, Meng Wu and Min Li</dc:creator>
			
			<dc:source>Virology Journal 2008, 5:109</dc:source>
			<dc:date>2008-09-26</dc:date>
			<dc:identifier>doi:10.1186/1743-422X-5-109</dc:identifier>
			
			
							
					<prism:publicationName>Virology Journal</prism:publicationName>
					
			
							
					<prism:issn>1743-422X</prism:issn>
					
			
							
					<prism:volume>5</prism:volume>
					
			
							
					<prism:startingPage>109</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-09-26</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.virologyj.com/content/5/1/108">
            
            <title>Discovery of frameshifting in Alphavirus 6K resolves a 20-year enigma</title>
			<description>Background:
The genus Alphavirus includes several potentially lethal human viruses.  Additionally, species such as Sindbis virus and Semliki Forest virus are important vectors for gene therapy, vaccination and cancer research, and important models for virion assembly and structural analyses.  The genome encodes nine known proteins, including the small '6K' protein.  6K appears to be involved in envelope protein processing, membrane permeabilization, virion assembly and virus budding.  In protein gels, 6K migrates as a doublet - a result that, to date, has been attributed to differing degrees of acylation.  Nonetheless, despite many years of research, its role is still relatively poorly understood.
Results:
We report that ribosomal -1 frameshifting, with an estimated efficiency of ~10-18%, occurs at a conserved UUUUUUA motif within the sequence encoding 6K, resulting in the synthesis of an additional protein, termed TF (TransFrame protein; ~8 kDa), in which the C-terminal amino acids are encoded by the -1 frame.  The presence of TF in the Semliki Forest virion was confirmed by mass spectrometry.  The expression patterns of TF and 6K were studied by pulse-chase labelling, immunoprecipitation and immunofluorescence, using both wild-type virus and a TF knockout mutant.  We show that it is predominantly TF that is incorporated into the virion, not 6K as previously believed.  Investigation of the 3' stimulatory signals responsible for efficient frameshifting at the UUUUUUA motif revealed a remarkable diversity of signals between different alphavirus species.
Conclusions:
Our results provide a surprising new explanation for the 6K doublet, demand a fundamental reinterpretation of existing data on the alphavirus 6K protein, and open the way for future progress in the further characterization of the 6K and TF proteins.  The results have implications for alphavirus biology, virion structure, viroporins, ribosomal frameshifting, and bioinformatic identification of novel frameshift-expressed genes, both in viruses and in cellular organisms.</description>
			<link>http://www.virologyj.com/content/5/1/108</link>
			
			 	<dc:creator>Andrew E Firth, Betty Y-W Chung, Marina N Fleeton and John F Atkins</dc:creator>
			
			<dc:source>Virology Journal 2008, 5:108</dc:source>
			<dc:date>2008-09-26</dc:date>
			<dc:identifier>doi:10.1186/1743-422X-5-108</dc:identifier>
			
			
							
					<prism:publicationName>Virology Journal</prism:publicationName>
					
			
							
					<prism:issn>1743-422X</prism:issn>
					
			
							
					<prism:volume>5</prism:volume>
					
			
							
					<prism:startingPage>108</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-09-26</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.virologyj.com/content/5/1/107">
            
            <title>Iota-Carrageenan is a potent inhibitor of rhinovirus infection</title>
			<description>Background:
Human rhinoviruses (HRVs) are the predominant cause of common cold. In addition, HRVs are implicated in the worsening of COPD and asthma, as well as the loss of lung transplants. Despite significant efforts, no anti-viral agent is approved for the prevention or treatment of HRV-infection.
Results:
In this study we demonstrate that Iota-Carrageenan, a sulphated polysaccharide derived from red seaweed, is a potent anti-rhinoviral substance in-vitro. Iota-Carrageenan reduces HRV growth and inhibits the virus induced cythopathic effect of infected HeLa cells. In addition, Iota-Carrageenan effectively prevents the replication of HRV1A, HRV2, HRV8, HRV14, HRV16, HRV83 and HRV84 in primary human nasal epithelial cells in culture. The data suggest that Iota-Carrageenan acts primarily by preventing the binding or the entry of virions into the cells.
Conclusion:
Since HRV infections predominately occur in the nasal cavity and the upper respiratory tract, a targeted treatment with a product containing Iota-Carrageenan is conceivable. Clinical trials are needed to determine whether Iota-Carrageenan-based products are effective in the treatment or prophylaxis of HRV infections.</description>
			<link>http://www.virologyj.com/content/5/1/107</link>
			
			 	<dc:creator>Andreas Grassauer, Regina Weinmuellner, Christiane Meier, Alexander Pretsch, Eva Prieschl-Grassauer and Hermann Unger</dc:creator>
			
			<dc:source>Virology Journal 2008, 5:107</dc:source>
			<dc:date>2008-09-26</dc:date>
			<dc:identifier>doi:10.1186/1743-422X-5-107</dc:identifier>
			
			
							
					<prism:publicationName>Virology Journal</prism:publicationName>
					
			
							
					<prism:issn>1743-422X</prism:issn>
					
			
							
					<prism:volume>5</prism:volume>
					
			
							
					<prism:startingPage>107</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-09-26</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.virologyj.com/content/5/1/106">
            
            <title>Transplacental transmission of Human Papillomavirus</title>
			<description>This paper aimed at studying the transplacental transmission of HPV and looking at the epidemiological factors involved in maternal viral infection. The following sampling methods were used: (1) in the pregnant woman, (a) genital; (b) peripheral blood; (2) in the newborn, (a) oral cavity, axillary and inguinal regions; (b) nasopharyngeal aspirate, and (c) cord blood; (3) in the placenta. The HPV DNA was identified using two methods: multiplex PCR of human beta-globin and of HPV using the PGMY09 and PGMY11 primers; and nested-PCR, which combines degenerated primers of the E6/E7 regions of the HPV virus, that allowed the identification of genotypes 6/11, 16, 18, 31, 33, 42, 52 and 58. Transplacental transmission was considered when type-specific HPV concordance was found between the mother, the placenta and the newborn or the mother and cord blood. The study included 49 HPV DNA-positive pregnant women at delivery. Twelve placentas (24.5%, n=12/49) had a positive result for HPV DNA. Eleven newborn were HPV DNA positive in samples from the nasopharyngeal or buccal and body or cord blood. In 5 cases (10.2%, n=5/49) there was HPV type-specific agreement between genital/placenta/newborn samples. In one case (2%, n=1/49) there was type specific HPV concordance between genital/cord blood and also suggested transplacental transmission. A positive and significant correlation was observed between transplacental transmission of HPV infection and the maternal variables of immunodepression (HIV, p=0.011). In conclusion the study suggests placental infection in 23.3% of the cases studied and transplacental transmission in 12.2%. It is suggested that in future HPV DNA be researched in the normal endometrium of women of reproductive age. The possible consequence of fetal exposure to HPV should be observed.</description>
			<link>http://www.virologyj.com/content/5/1/106</link>
			
			 	<dc:creator>Renato L Rombaldi, Eduardo P Serafini, Jovana Mandelli, Edineia Zimmermann and Kamille P Losquiavo</dc:creator>
			
			<dc:source>Virology Journal 2008, 5:106</dc:source>
			<dc:date>2008-09-25</dc:date>
			<dc:identifier>doi:10.1186/1743-422X-5-106</dc:identifier>
			
			
							
					<prism:publicationName>Virology Journal</prism:publicationName>
					
			
							
					<prism:issn>1743-422X</prism:issn>
					
			
							
					<prism:volume>5</prism:volume>
					
			
							
					<prism:startingPage>106</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-09-25</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
		
    <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
         <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks"/>
	</cc:License>
</rdf:RDF>
